Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

4.59
Delayed Data
As of Sep 26
 -0.06 / -1.29%
Today’s Change
3.15
Today|||52-Week Range
8.78
-26.91%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close4.65
Today’s open4.65
Day’s range4.56 - 4.69
Volume45,361
Average volume (3 months)94,285
Market cap$128.2M
Dividend yield--
Data as of 09/26/2016

Growth & Valuation

Earnings growth (last year)+62.50%
Earnings growth (this year)-7.08%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
MSLIMerus Labs Internati...-0.01-0.92%
TTNPTitan Pharmaceutical...-0.07-1.16%
NVLSNivalis Therapeutics...-0.02-0.24%
OCXOncoCyte Corp+0.24+4.85%
Data as of 09/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$19.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Search for Jobs